Last reviewed by Daniel Gana and Dr. Abraham Benavides, MD, 11-15-2024

Aging is a universal process characterized by a decline in physical and mental function, driven by oxidative stress, inflammation, and cellular degradation. For years, the search for effective anti-aging treatments has led to various synthetic drugs and interventions. 

Cannabis, however, with its several therapeutic properties, is emerging as a promising natural alternative. This article explores how cannabis combats the aging process by leveraging its rich array of cannabinoids, terpenes, and flavonoids, highlighting research studies and the synergy of whole plant extracts for maximum anti-aging potential.

The Biological Drivers of Aging

Aging is characterized by cellular damage,  inflammation, oxidative stress, and a slowing of neurogenesis (creating new brain cells). These changes speed up the onset of age-related conditions such as neurodegenerative disorders like Alzheimer’s and Parkinson’s, arthritis, heart disease, cognitive decline, cancer, and other health issues.

The endocannabinoid system (ECS), the body’s regulatory and defense network, is crucial for maintaining cellular balance and controlling inflammation. This is why scientists and consumers are increasingly turning to cannabinoids as a potential tool to slow down aging.

How Cannabis Reduces or Reverses Aging

Cannabis interacts with the ECS by primarily modulating CB1 and CB2 receptors. These receptors are crucial in managing immune responses, neuroprotection, and inflammation. 

As we age, the abundance and functionality of these receptors decreases, leading to a breakdown in cellular regulation. Cannabinoids, particularly THC, CBD, and CBG, may restore this balance, offering natural mechanisms to mitigate the effects of aging. These include:
 –

1. Reduction of Inflammation: Chronic inflammation is a hallmark of aging; its influence is sometimes referred to as “inflammaging”. Studies show that cannabinoids like CBD and THC reduce inflammation by interacting with the immune system and inhibiting the release of pro-inflammatory cytokines.
2. Antioxidant Effects: Cannabinoids like CBD and CBGA are potent antioxidants, neutralizing free radicals that damage cells and tissues. This reduces oxidative stress, a primary contributor to age-related diseases.
3. Neurogenesis and Cognitive Protection: THC and CBD, especially in low doses, are shown to stimulate neurogenesis in preclinical models, promoting the creation of new neurons. This process may protect the brain from degenerative conditions like Alzheimer’s, preserving cognitive function as we age.
4. Mitochondrial Health: Cannabinoids such as CBN and CBGA have shown potential in preserving mitochondrial function, which is critical for maintaining energy levels and cellular longevity.
5. Attenuate Gut Dysbiosis: Cannabinoids like CBD and THC can regulate gut microbes and reduce inflammation throughout the gut-brain-bone axis. This causes beneficial and preventative downstream effects for potentially alleviating or preventing chronic, metabolic (e.g. diabetes, obesity, cardiovascular disease), gastrointestinal (e.g., IBD, IBS, regulating gut motility), and neurodegenerative diseases (e.g. Alzheimer’s, Parkinson’s, etc.). 

Key Research Studies on Cannabis and Aging

Several groundbreaking studies have highlighted the role of cannabis in slowing down or even reversing age-related decline:
–

• Low-Dose THC and Cognitive Function: An earlier study conducted in Germany and Israel (2017) found that administering a chronic low dose of THC restored cognitive function in old mice, demonstrating its potential in reversing cognitive decline. These results are replicable and are still supported in recent years.
• CB2 Activation with β-Caryophyllene: Research in 2019 shows that β-caryophyllene, a terpene abundantly found in cannabis, activates CB2 receptors, reducing inflammation and improving working memory in aged male mice.
• Cannabinoid Protection of Mitochondria: Recent studies reveal that CBN and CBGA protect mitochondria from oxidative damage, a key factor in age-related neurodegenerative diseases.

Anti-Aging Compounds in Cannabis

Cannabis contains a variety of cannabinoids, terpenes, and flavonoids that contribute to its anti-aging properties:
–

1. CBD (Cannabidiol): Known for its antioxidant and anti-inflammatory effects, CBD promotes cellular repair, reduces oxidative stress, and enhances neurogenesis. This makes it a cornerstone of cannabis-based anti-aging therapies. New research also suggests modification of ACE2 by high-CBD cultivars may also yield protective effects against inflammaging in the setting of COVID-19 infection.
2. THC (Tetrahydrocannabinol): Low doses of THC improve cognitive function by stimulating neurogenesis and reducing inflammation. Its anti-inflammatory effects also help alleviate chronic conditions associated with aging, such as arthritis.
3. CBN (Cannabinol): CBN is increasingly recognized for its mitochondrial protection, reducing oxidative stress and neuroinflammation, which are key factors in aging.
4. CBG (Cannabigerol): CBG acts as a neuroprotectant and anti-inflammatory, showing promise for preserving brain health and reducing inflammation that contributes to aging.
5. CBGA (Cannabigerolic Acid): CBGA, the precursor to CBG, is also a powerful neuroprotective antioxidant, helping to neutralize free radicals and protect cellular health.
6. THCA (Tetrahydryocannabinolic acid): Parent of THC exhibiting anti-inflammatory, neuroprotective, and anticonvulsant effects. Recently, THCA and CBDA are shown to rescue memory deficits and reduce amyloid-beta and tau pathology in mouse models of Alzheimer’s disease.
7. CBDA (Cannabidiolic Acid): CBDA exhibits strong anti-inflammatory properties, and early research suggests it plays a significant role in reducing stress, a key factor in accelerating the aging process.

The Entourage Effect and Whole Plant Extracts

One of the most significant advantages of using cannabis for anti-aging is the entourage effect, the synergistic interaction of cannabinoids, terpenes, and flavonoids. Whole plant extracts, which contain the full spectrum of these compounds, offer greater therapeutic potential than isolated cannabinoids alone.
–

• Terpenes and Flavonoids: Terpenes like β-caryophyllene and flavonoids like quercetin complement the effects of cannabinoids, providing additional antioxidant and anti-inflammatory benefits.
• Bioidentical Botanical Profile: Whole plant extracts that mimic the natural balance of cannabinoids, terpenes, and flavonoids in the cannabis plant provide a more comprehensive approach to anti-aging by targeting multiple pathways such as oxidative stress, inflammation, and neuroprotection.

The Future of Cannabis in Anti-Aging Therapies

As research continues to advance, cannabis is positioned to become a leading natural therapy for mitigating the effects of aging. With its ability to reduce inflammation, protect neurons, regulate ACE2, and enhance mitochondrial function, cannabis offers a promising solution for those seeking to maintain their health and vitality as they age. 

However, further clinical trials are needed to fully confirm benefits and understand optimal dosages and delivery methods for specific anti-aging outcomes.

Conclusion

Cannabis offers a multifaceted approach to combating the effects of aging. From its antioxidant and anti-inflammatory properties to its ability to promote neurogenesis and protect mitochondrial health, cannabis is paving the way for natural anti-aging solutions. 

By using whole plant extracts, individuals can harness the full spectrum of benefits that cannabis offers, potentially revolutionizing the field of anti-aging therapies.

References

1. A, D. S., Mg, E., & G, M. (2008). Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay. Mutation Research, 653(1–2). https://doi.org/10.1016/j.mrgentox.2008.04.004
2. Aliev, G., Liu, J., Shenk, J. C., Fischbach, K., Pacheco, G. J., Chen, S. G., Obrenovich, M. E., Ward, W. F., Richardson, A. G., Smith, M. A., Gasimov, E., Perry, G., & Ames, B. N. (2009). Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats. Journal of Cellular and Molecular Medicine, 13(2), 320–333. https://doi.org/10.1111/j.1582-4934.2008.00324.x
3. Al-Khazaleh, A. K., Zhou, X., Bhuyan, D. J., Münch, G. W., Al-Dalabeeh, E. A., Jaye, K., & Chang, D. (2024). The Neurotherapeutic Arsenal in Cannabis sativa: Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects. Molecules, 29(2), Article 2. https://doi.org/10.3390/molecules29020410
4. Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019). Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants, 9(1), 21. https://doi.org/10.3390/antiox9010021
5. Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011). Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature, 479(7372), 232–236. https://doi.org/10.1038/nature10600
6. Bilkei-Gorzo, A. (2012). The endocannabinoid system in normal and pathological brain ageing. Philosophical Transactions of the Royal Society B: Biological Sciences, 367(1607), 3326–3341. https://doi.org/10.1098/rstb.2011.0388
7. Bilkei-Gorzo, A., Albayram, O., Draffehn, A., Michel, K., Piyanova, A., Oppenheimer, H., Dvir-Ginzberg, M., Rácz, I., Ulas, T., Imbeault, S., Bab, I., Schultze, J. L., & Zimmer, A. (2017). A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nature Medicine, 23(6), 782–787. https://doi.org/10.1038/nm.4311
8. Chacon, F. T., Raup-Konsavage, W. M., Vrana, K. E., & Kellogg, J. J. (2022). Secondary Terpenes in Cannabis sativa L.: Synthesis and Synergy. Biomedicines, 10(12), 3142. https://doi.org/10.3390/biomedicines10123142
9. Costa, L. G., Garrick, J. M., Roquè, P. J., & Pellacani, C. (2016). Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More. Oxidative Medicine and Cellular Longevity, 2016(1), 2986796. https://doi.org/10.1155/2016/2986796
10. Dd, D., Da, S., & Wv, F. (2001). Positive emotions in early life and longevity: Findings from the nun study. Journal of Personality and Social Psychology, 80(5). https://pubmed.ncbi.nlm.nih.gov/11374751/
11. Di Meo, C., Tortolani, D., Standoli, S., Angelucci, C. B., Fanti, F., Leuti, A., Sergi, M., Kadhim, S., Hsu, E., Rapino, C., & Maccarrone, M. (2022). Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes. International Journal of Molecular Sciences, 23(10), Article 10. https://doi.org/10.3390/ijms23105430
12. Ellingson, J. M., Hinckley, J. D., Ross, J. M., Schacht, J. P., Bidwell, L. C., Bryan, A. D., Hopfer, C. J., Riggs, P., & Hutchison, K. E. (2021). The Neurocognitive Effects of Cannabis Across the Lifespan. Current Behavioral Neuroscience Reports, 8(4), 124–133. https://doi.org/10.1007/s40473-021-00244-7
13. Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018). Inflammaging: A new immune–metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology, 14(10), 576–590. https://doi.org/10.1038/s41574-018-0059-4
14. G, J., Be, Ő., Ce, V., Cm, R., A, T.-V., & A, P. (2023). Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance. Antioxidants (Basel, Switzerland), 12(2). https://doi.org/10.3390/antiox12020485
15. Gęgotek, A., Jarocka-Karpowicz, I., Ekiner, S. A., & Skrzydlewska, E. (2023). The Anti-Inflammatory Action of Cannabigerol Accompanied by the Antioxidant Effect of 3-O-ethyl Ascorbic Acid in UVA-Irradiated Human Keratinocytes. Journal of Pharmacology and Experimental Therapeutics, 387(2), 170–179. https://doi.org/10.1124/jpet.123.001731
16. Ibrahim, I., Syamala, S., Ayariga, J. A., Xu, J., Robertson, B. K., Meenakshisundaram, S., & Ajayi, O. S. (2022). Modulatory Effect of Gut Microbiota on the Gut-Brain, Gut-Bone Axes, and the Impact of Cannabinoids. Metabolites, 12(12), 1247. https://doi.org/10.3390/metabo12121247
17. Jacobs, T. L., Epel, E. S., Lin, J., Blackburn, E. H., Wolkowitz, O. M., Bridwell, D. A., Zanesco, A. P., Aichele, S. R., Sahdra, B. K., MacLean, K. A., King, B. G., Shaver, P. R., Rosenberg, E. L., Ferrer, E., Wallace, B. A., & Saron, C. D. (2011). Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology, 36(5), 664–681. https://doi.org/10.1016/j.psyneuen.2010.09.010
18. Jonsson, K.-O., Vandevoorde, S., Lambert, D. M., Tiger, G., & Fowler, C. J. (2001). Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. British Journal of Pharmacology, 133(8), 1263–1275. https://doi.org/10.1038/sj.bjp.0704199
19. Kataoka, K., Bilkei-Gorzo, A., Nozaki, C., Togo, A., Nakamura, K., Ohta, K., Zimmer, A., & Asahi, T. (2020). Age-dependent Alteration in Mitochondrial Dynamics and Autophagy in Hippocampal Neuron of Cannabinoid CB1 Receptor-deficient Mice. Brain Research Bulletin, 160, 40–49. https://doi.org/10.1016/j.brainresbull.2020.03.014
20. Kim, J., Choi, P., Park, Y.-T., Kim, T., Ham, J., & Kim, J.-C. (2023). The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer’s Disease-like Mouse Model. International Journal of Molecular Sciences, 24(7), Article 7. https://doi.org/10.3390/ijms24076827
21. Liang, Z., Soriano-Castell, D., Kepchia, D., Duggan, B. M., Currais, A., Schubert, D., & Maher, P. (2022). Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors. Free Radical Biology and Medicine, 180, 33–51. https://doi.org/10.1016/j.freeradbiomed.2022.01.001
22. Lindsey, L. P., Daphney, C. M., Oppong-Damoah, A., Uchakin, P. N., Abney, S. E., Uchakina, O. N., Khusial, R. D., Akil, A., & Murnane, K. S. (2019). The cannabinoid receptor 2 agonist, β-caryophyllene, improves working memory and reduces circulating levels of specific proinflammatory cytokines in aged male mice. Behavioural Brain Research, 372, 112012. https://doi.org/10.1016/j.bbr.2019.112012
23. Marchalant, Y., Brothers, H. M., Norman, G. J., Karelina, K., DeVries, A. C., & Wenk, G. L. (2009). Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis. Neurobiology of Disease, 34(2), 300–307. https://doi.org/10.1016/j.nbd.2009.01.014
24. Morsanuto, V., Galla, R., Molinari, C., & Uberti, F. (2020). A New Palmitoylethanolamide Form Combined with Antioxidant Molecules to Improve Its Effectivess on Neuronal Aging. Brain Sciences, 10(7), 457. https://doi.org/10.3390/brainsci10070457
25. News, N. (2022, January 25). Active Ingredient in Cannabis Protects Aging Brain Cells. Neuroscience News. https://neurosciencenews.com/cannabinol-brain-aging-19962/
26. Ni, B., Liu, Y., Dai, M., Zhao, J., Liang, Y., Yang, X., Han, B., & Jiang, M. (2023). The role of cannabidiol in aging. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 165, 115074. https://doi.org/10.1016/j.biopha.2023.115074
27. O’Croinin, C., Garcia Guerra, A., Doschak, M. R., Löbenberg, R., & Davies, N. M. (2023). Therapeutic Potential and Predictive Pharmaceutical Modeling of Stilbenes in Cannabis sativa. Pharmaceutics, 15(7), 1941. https://doi.org/10.3390/pharmaceutics15071941
28. Ostir, G. V., Markides, K. S., Black, S. A., & Goodwin, J. S. (2000). Emotional Well-Being Predicts Subsequent Functional Independence and Survival. Journal of the American Geriatrics Society, 48(5), 473–478. https://doi.org/10.1111/j.1532-5415.2000.tb04991.x
29. Pandelides, Z., Thornton, C., Faruque, A. S., Whitehead, A. P., Willett, K. L., & Ashpole, N. M. (2020). Developmental exposure to cannabidiol (CBD) alters longevity and health span of zebrafish (Danio rerio). GeroScience, 42(2), 785–800. https://doi.org/10.1007/s11357-020-00182-4
30. Pandelides, Z., Thornton, C., Lovitt, K. G., Faruque, A. S., Whitehead, A. P., Willett, K. L., & Ashpole, N. M. (2020). Developmental exposure to Δ9-tetrahydrocannabinol (THC) causes biphasic effects on longevity, inflammation, and reproduction in aged zebrafish (Danio rerio). GeroScience, 42(3), 923–936. https://doi.org/10.1007/s11357-020-00175-3
31. Paradisi, A., Oddi, S., & Maccarrone, M. (2006). The endocannabinoid system in ageing: A new target for drug development. Current Drug Targets, 7(11), 1539–1552. https://doi.org/10.2174/1389450110607011539
32. Pocuca, N., Walter, T. J., Minassian, A., Young, J. W., Geyer, M. A., & Perry, W. (2020). The Effects of Cannabis Use on Cognitive Function in Healthy Aging: A Systematic Scoping Review. Archives of Clinical Neuropsychology, 36(5), 673–685. https://doi.org/10.1093/arclin/acaa105
33. Russo, E. B. (2019). The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain. Frontiers in Plant Science, 9. https://doi.org/10.3389/fpls.2018.01969
34. Salk Institute. (2022, January 25). Cannabinol CBN – Rare Cannabinoid Under Development for Glaucoma. InMed Pharmaceuticals. https://www.inmedpharma.com/pharmaceutical/inm-088-for-glaucoma/
35. Schiano Moriello, A., Di Marzo, V., & Petrosino, S. (2022). Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint. Animals, 12(3), Article 3. https://doi.org/10.3390/ani12030348
36. Schulz, T. J., Zarse, K., Voigt, A., Urban, N., Birringer, M., & Ristow, M. (2007). Glucose Restriction Extends Caenorhabditis elegans Life Span by Inducing Mitochondrial Respiration and Increasing Oxidative Stress. Cell Metabolism, 6(4), 280–293. https://doi.org/10.1016/j.cmet.2007.08.011
37. Suliman, N. A., Taib, C. N. M., Moklas, M. A. M., & Basir, R. (2018). Delta-9-Tetrahydrocannabinol (∆9-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats. Neurotoxicity Research, 33(2), 402–411. https://doi.org/10.1007/s12640-017-9806-x
38. Suryavanshi, S. V., Kovalchuk, I., & Kovalchuk, O. (2021). Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective. Frontiers in Immunology, 11, 613613. https://doi.org/10.3389/fimmu.2020.613613
39. Suzuki, S., Wakano, C., Monteilh-Zoller, M. K., Cullen, A. J., Fleig, A., & Penner, R. (2023). Cannabigerolic Acid (CBGA) Inhibits the TRPM7 Ion Channel Through its Kinase Domain. Function, 5(1), zqad069. https://doi.org/10.1093/function/zqad069
40. Terracciano, A., Löckenhoff, C. E., Zonderman, A. B., Ferrucci, L., & Costa, P. T. (2008). Personality predictors of longevity: Activity, emotional stability, and conscientiousness. Psychosomatic Medicine, 70(6), 621–627. https://doi.org/10.1097/PSY.0b013e31817b9371
41. Valeri, A., & Mazzon, E. (2021). Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration? Molecules, 26(20), 6313. https://doi.org/10.3390/molecules26206313
42. Wang, B., Kovalchuk, A., Li, D., Rodriguez-Juarez, R., Ilnytskyy, Y., Kovalchuk, I., & Kovalchuk, O. (2020). In search of preventive strategies: Novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues. Aging (Albany NY), 12(22), 22425–22444. https://doi.org/10.18632/aging.202225
43. Yoo, H. B., DiMuzio, J., & Filbey, F. M. (2020). Interaction of Cannabis Use and Aging: From Molecule to Mind. Journal of Dual Diagnosis, 16(1), 140–176. https://doi.org/10.1080/15504263.2019.1665218